FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

21387011000001102: Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Nov 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71122701000001113 Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103839401000001114 Zinforo 600mg powder for concentrate for solution for infusion vials (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Is a Ceftaroline fosamil 600mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has specific active ingredient Ceftaroline fosamil acetic acid solvate monohydrate false Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ceftaroline fosamil false Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Is a Zinforo true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ceftaroline fosamil true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has active ingredient Substance with cephalosporin structure and antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has basis of strength substance Ceftaroline fosamil true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has specific active ingredient Ceftaroline fosamil acetic acid solvate monohydrate true Inferred relationship Existential restriction modifier
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) 10 vial Has AMP True Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start